(Q35043395)

6 August 2017

1 reference

title

Evidence of the economic benefit of clinical pharmacy services: 1996-2000. (English)

1 reference

6 August 2017

0 references

Glen T Schumock

1

1 reference

6 August 2017

Melissa G Butler

2

1 reference

6 August 2017

Patrick D Meek

3

1 reference

6 August 2017

Lee C Vermeulen

4

1 reference

6 August 2017

Bhakti V Arondekar

5

1 reference

6 August 2017

Jerry L Bauman

6

1 reference

6 August 2017

2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

113-132

1 reference

Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

A review of the pharmacoeconomics of pharmaceutical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Decrease in emergency room or urgent care visits due to management of bronchial asthma inpatients and outpatients with pharmaceutical services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Pharmaceutical care in medical progressive care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Clinical guidelines and pharmacist intervention program for HIV-infected patients requiring granulocyte colony-stimulating factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Evaluation of a computer-assisted antibiotic-dose monitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Economic impact of a drug information service.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Antibiotic optimization. An evaluation of patient safety and economic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical C

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

The health care cost of drug-related morbidity and mortality in nursing facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

The impact of pharmacist interventions on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

Economic evaluation of pharmacy services--fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.113.31910

10.1592/PHCO.23.1.113.31910

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference